Shire has acquired Meritage for an upfront fee of $70 million and additional contingent payments Read the full story

Read the full story

Shire and NPS Pharmaceuticals have entered into a merger agreement pursuant to which Shire will acquire all the outstanding shares of NPS Pharma for $46.00 per share in cash, for a total consideration of approximately $5.2 billion Read the full story

In response to recent changes to the U.S. tax code to discourage so-called tax inversion deals, Chicago-based AbbVie recently indicated it was rethinking its $54 billion takeover bid of U.K.-based Shire. Read the full story

Shire and ArmaGen announced a worldwide pharma licensing and collaboration agreement for AGT-182. Read the full story

Shire has finally agreed for an m&a agreement with AbbVie for $54 billion. Read the full story

Shire rejects Abbvie's $46 billion bid for acquisition. Read the full story

arGEN-X has entered into a long-term strategic alliance with Shire Pharmaceuticals. Read the full story

London-listed drugmaker Shire is considering a bid for New Jersey-based NPS Pharmaceuticals, FT Alphaville reported on Friday citing sources. Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story